|
1 Company |
|
1 Product |
|
1 Product |
|
0 Mechanisms of Action |
|
0 Trials |
|
14 News |
|
- progesterone / Generic mfg.
Enrollment change, Trial withdrawal: Progesterone for First Trimester Vaginal Bleeding (clinicaltrials.gov) - Oct 26, 2016
P=N/A, N=0, Withdrawn, Sponsor: Soroka University Medical Center
N=200 --> 0 | Not yet recruiting --> Withdrawn
- Enrollment change: HEMOGYN: Proof of Concept Study of a Sucker Hemostatic Intra Uterine in Postpartum Hemorrhage After Abruptio Placenta Assisted (clinicaltrials.gov) - Oct 18, 2016
P=N/A, N=1, Terminated, Sponsor: AdministrateurCIC
N=200 --> 0 | Not yet recruiting --> Withdrawn N=15 --> 1
- Trial completion, Enrollment change: Comparing Blood Loss During Caesarean Section Between Manual Separation of Placenta & Conservative Management (clinicaltrials.gov) - Mar 4, 2016
P=N/A, N=838, Completed, Sponsor: Kasr El Aini Hospital
N=15 --> 1 Recruiting --> Completed | N=548 --> 838
- enoxaparin sodium / Generic mfg.
Trial completion: Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome (clinicaltrials.gov) - Feb 23, 2016
P=N/A, N=144, Completed, Sponsor: HaEmek Medical Center, Israel
Recruiting --> Completed | N=548 --> 838 Active, not recruiting --> Completed
- | enoxaparin sodium / Generic mfg.
Trial completion, Trial primary completion date: HEPEPE: Prevention of Maternal and Perinatal Complications by Enoxaparin in Women With Previous Severe Preeclampsia (clinicaltrials.gov) - Jan 20, 2016
P3, N=257, Completed, Sponsor: Assistance Publique - H
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Feb 2015 --> Nov 2015
- | enoxaparin sodium / Generic mfg.
Enrollment closed: HEPEPE: Prevention of Maternal and Perinatal Complications by Enoxaparin in Women With Previous Severe Preeclampsia (clinicaltrials.gov) - Jul 14, 2015
P3, N=256, Active, not recruiting, Sponsor: Assistance Publique - H
Active, not recruiting --> Completed | Trial primary completion date: Feb 2015 --> Nov 2015 Recruiting --> Active, not recruiting
- New trial: Comparing Blood Loss During Caesarean Section Between Manual Separation of Placenta & Conservative Management (clinicaltrials.gov) - Jun 24, 2015
P=N/A, N=548, Recruiting, Sponsor: Kasr El Aini Hospital
- enoxaparin sodium / Generic mfg.
Enrollment closed: Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome (clinicaltrials.gov) - Jun 16, 2015
P=N/A, N=144, Active, not recruiting, Sponsor: HaEmek Medical Center, Israel
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- enoxaparin sodium / Generic mfg.
Trial primary completion date: Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome (clinicaltrials.gov) - Apr 19, 2015
P=N/A, N=144, Recruiting, Sponsor: HaEmek Medical Center, Israel
Recruiting --> Active, not recruiting Trial primary completion date: Sep 2014 --> Feb 2015
- Enrollment change, Trial termination: The Use of Fetal Fibronectin to Predict Delivery Due to Abruptio Placenta (clinicaltrials.gov) - Jan 12, 2015
P=N/A, N=3, Terminated, Sponsor: Winthrop University Hospital
Trial primary completion date: Sep 2014 --> Feb 2015 N=300 --> 3 | Recruiting --> Terminated; Quantitative assessment of fFN only able to be performed at one laboratory.
- Enrollment closed: Magnesium Sulfate vs Placebo for Placental Abruption (clinicaltrials.gov) - Nov 19, 2014
P=N/A, N=48, Active, not recruiting, Sponsor: Stanford University
N=300 --> 3 | Recruiting --> Terminated; Quantitative assessment of fFN only able to be performed at one laboratory. Recruiting --> Active, not recruiting
- enoxaparin sodium / Generic mfg.
Trial primary completion date: HEPEPE: Prevention of Maternal and Perinatal Complications by Enoxaparin in Women With Previous Severe Preeclampsia (clinicaltrials.gov) - Oct 30, 2014
P3, N=255, Recruiting, Sponsor: Assistance Publique - H
Recruiting --> Active, not recruiting Trial primary completion date: Feb 2014 --> Feb 2015
- Enrollment closed: HEMOGYN: Proof of Concept Study of a Sucker Hemostatic Intra Uterine in Postpartum Hemorrhage After Abruptio Placenta Assisted (clinicaltrials.gov) - Apr 9, 2014
P=N/A, N=15, Active, not recruiting, Sponsor: AdministrateurCIC
Trial primary completion date: Feb 2014 --> Feb 2015 Recruiting --> Active, not recruiting
- | enoxaparin sodium / Generic mfg.
Enrollment change: HEPEPE: Prevention of Maternal and Perinatal Complications by Enoxaparin in Women With Previous Severe Preeclampsia (clinicaltrials.gov) - Aug 4, 2013
P3, N=255, Recruiting, Sponsor: Assistance Publique - H
Recruiting --> Active, not recruiting N=440 --> 255